Efficacy and Safety of Pregabalin in Treatment of Neuropathic Pain in Patients With Idiopathic Small Fiber Neuropathy
Phase of Trial: Phase II
Latest Information Update: 09 Mar 2017
At a glance
- Drugs Pregabalin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- 06 Mar 2017 Planned End Date changed from 1 Sep 2017 to 1 Oct 2017.
- 06 Mar 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Oct 2017.
- 20 Nov 2015 New trial record